Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

欧洲大型分析显示当前 NSAID 使用与心力衰竭的风险增加相关

Michael O'Riordan

September 30, 2016

News Daily News

Según un Extenso Análisis Europeo el Uso Actual de FAINE se asocia a un Mayor Riesgo de Insuficiencia Cardíaca

Michael O'Riordan

September 30, 2016

News Daily News

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

Michael O'Riordan

September 30, 2016

News Daily News

El Uso Concomitante FAINE+Tratamiento Antitrombótico Aumenta las Hemorragias y los Episodios CV Post-IM

Yael L. Maxwell

February 25, 2015

News Daily News

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Yael L. Maxwell

February 25, 2015

News Daily News

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Caitlin E. Cox

June 03, 2013

News Daily News

Meta-análisis confirma relación entre la dosis alta de FAINE y el riesgo vascular

Caitlin E. Cox

June 03, 2013

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

Presentation

Mini-COREA: Celecoxib, una Espada de Doble Filo para Pacientes con Angina

Presenter: H. J. Kang

March 14, 2012

Presentation

Mini-COREA: Celecoxib, a Double-edged Sword for Patients with Angina

Presenter: H.J. Kang

March 14, 2012

Advertisement

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

欧洲大型分析显示当前 NSAID 使用与心力衰竭的风险增加相关

Según un Extenso Análisis Europeo el Uso Actual de FAINE se asocia a un Mayor Riesgo de Insuficiencia Cardíaca

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

El Uso Concomitante FAINE+Tratamiento Antitrombótico Aumenta las Hemorragias y los Episodios CV Post-IM

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Meta-análisis confirma relación entre la dosis alta de FAINE y el riesgo vascular

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Mini-COREA: Celecoxib, una Espada de Doble Filo para Pacientes con Angina

Mini-COREA: Celecoxib, a Double-edged Sword for Patients with Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content